Our Company

Close-up image of Saint Louis Gateway Arch. Gateway Biotechnology

Nearly 40 million Americans have some degree of hearing loss. Devices are available to protect against noise but they are not always effective, can be impractical to use, and cannot help people with age-related or drug-induced hearing loss.

Since 2011, Gateway has taken a science-based approach. We focus on drug repurposing – a cost-effective strategy – to prevent or treat hearing disorders with a short development cycle. FDA-approved drugs and herbal medicines have been studied extensively for safety in humans and abundant pharmacological information is already available.

Top-down view of street and park in Saint Louis. Gateway Biotechnology

Market Opportunity

Graphic of people. Gateway Biotechnology.
15% of people in the U.S. have tinnitus
Graphic of chart showing improvement. Gateway Biotechnology.
$10+ billion
U.S. hearing market potential
Graphic of a pill capsule. Gateway Biotechnology.
​No current FDA-approved drugs for hearing disorders